a maker of biologic therapeutics for oncology and inflammatory diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with AURA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then AURA could also see price increases.
Ticker / NAME | Correlation To CHRS | 1D Price Change % | ||
---|---|---|---|---|
CHRS | 100% | -2.16% | ||
AURA - CHRS | 51% Loosely correlated | -7.04% | ||
ABCL - CHRS | 45% Loosely correlated | -2.34% | ||
MDXG - CHRS | 43% Loosely correlated | -6.73% | ||
DNLI - CHRS | 43% Loosely correlated | +2.78% | ||
MGTX - CHRS | 41% Loosely correlated | -3.93% | ||
More |
Ticker / NAME | Correlation To CHRS | 1D Price Change % |
---|---|---|
CHRS | 100% | -2.16% |
cancer theme (87 stocks) | 55% Loosely correlated | +0.89% |
drugs theme (265 stocks) | 51% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 47% Loosely correlated | +5.56% |
therapeutics theme (57 stocks) | 46% Loosely correlated | +20.54% |
oncology theme (18 stocks) | 40% Loosely correlated | +0.37% |
More |